Logo

List of Chronobiotics



Name SMILES FDA Status Effects Targets Mechanisms Articles
CC(=CCC1=CC(=C(C=C1O)O)C(=O)/C=C/C2=CC=C(C=C2)O)C none RORA , RORα ROR
C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)O Not approved p38 MAP kinase Inhibits p38 MAPK α/β isoforms
CCC(=O)NC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 not approved Melatonin receptor antagonist of melatonin receptors
CC1=CC(=C(C=C1)C(C2=CC=CC=C2)NC(=O)CC3=CC4=C(C=C3)OC(=C4)C(C5=C(ON=C5C)C)O)C Not approved RORα ROR
C1=CC(=C(C=C1/C=C/C(=O)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/C2=CC(=C(C=C2)O)O)C(=O)O)O)O none PGC-1α , CLOCK-BMAL1 , GSK-3α/β PGC-1α interaction, Core clock modulation, Activation of CLOCK/Bmal1 mediated transcription, Interferes with CLOCK–BMAL1, Selective GSK-3β Inhibition:, Circadian Clock Impact, inhibits glycogen synthase kinase-3β (GSK-3β)
CC1=C(C=CC(=C1)S(=O)(=O)N2CCCCC2)OC Not approved Melanopsin (Opn4) Competitive blockade of melanopsin’s retinal-binding site
CC(=O)NCCC1=CNC2=C1C=C(C=C2)NC(=O)OC not approved MT3 MT3 receptor ligand
CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC Approved CLOCK-BMAL1 , BMAL1 expression (induction) Bmal1, de-repressing BMAL1, BMAL1 expression modulation, BMAL1 expression modulation, mTOR signaling inhibition, Serine/threonine-protein kinase mTOR
C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O None PER2 gene expression BMAL1 expression modulation
CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2 Approved Melatonin receptor , MT1 , MT2 Melatonin receptor binding, MT1 receptor binding, MT2 receptor ligand
C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O Approved CLOCK-BMAL1 , BMAL1 expression (induction) , Fe Bmal1, BMAL1 expression modulation, BMAL1 expression modulation
CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OCCCOC3=CC4=C(C=CC=C4CCNC(=O)C)C=C3 not approved Melatonin receptor , MT1 , MT2 Melatonin receptor binding, MT2 receptor antagonist, MT1 receptor binding
CCNC(=O)CC[C@@H](C(=O)O)N none BMAL1 expression (induction) de-repressing BMAL1, BMAL1 expression modulation, BMAL1 expression modulation
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO Approved CLOCK-BMAL1 , BMAL1 expression (induction) Bmal1, BMAL1 expression modulation, BMAL1 expression modulation, "Tyrosine-protein kinase ABL1, Lck, Yes, Fyn, BTK, CSK, Fgr, FRK, Lyn Proto-oncogene tyrosine-protein kinase Src Ephrin type-A
COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3 Not approved Melatonin receptor , MT3 , MT1 , MT2 MT3 receptor ligand, MT1 receptor binding, MT2 receptor ligand
CC(C(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3)O Not approved Melatonin receptor , MT1 , MT2 Melatonin receptor binding, MT1 receptor binding, MT2 receptor ligand
CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC Approved CLOCK-BMAL1 BMAL1 expression modulation
C1=CC(=C(C=C1/C=C/C2=CC(=CC(=C2)O)O)O)O Not approved Per2 expression , Per 1 expression (gene) PER gene exspression modulation
CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C Approved CLOCK-BMAL1 , Arntl (gene) , BMAL1 expression (induction) Bmal1, de-repressing BMAL1, BMAL1 expression modulation, BMAL1 expression modulation, DNA polymerase/reverse transcriptase (HBV-D) binding
[2H]C([2H])([2H])C(=O)NCCC1=CNC2=C1C=C(C=C2)OC Approved MT1 Melatonin receptor binding
CC(C(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3)O Approved Melatonin receptor Melatonin agonist
CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 approved CLOCK-BMAL1 BMAL1 expression modulation
CCCC(=O)NCCC1=C2C=C(C=CC2=CN=N1)OC Not approved MT1 , MT2 Melatonin receptor binding
C1=CC=C2C(=C1)C=CN2 not approved Melatonin receptor Melatonin receptor binding
C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl approved CLOCK-BMAL1 Modulates sleep architecture via H1-histamine receptor antagonism